SynCore Biotechnology Company Overview
- Year Founded
-
2008

- Status
-
Public
- Employees
-
33

- Stock Symbol
-
4192

- Share Price
-
$0.92
- (As of Tuesday Closing)
SynCore Biotechnology Company General Information
Description
SynCore Biotechnology Co Ltd is a Biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.
Contact Information
Website
www.syncorebio.comCorporate Office
- 84 Chung Shan Road
- Chung Shan Village
- Yilan City, Tung-Shan 269
- Taiwan
Corporate Office
- 84 Chung Shan Road
- Chung Shan Village
- Yilan City, Tung-Shan 269
- Taiwan
SynCore Biotechnology Company Stock Performance
As of 29-Apr-2025, SynCore Biotechnology Company’s stock price is $0.92. Its current market cap is $32.4M with 35.2M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.92 | $0.92 | $0.75 - $1.50 | $32.4M | 35.2M | 8.4K | -$0.05 |
SynCore Biotechnology Company Financials Summary
As of 31-Dec-2024, SynCore Biotechnology Company has a trailing 12-month revenue of $727K.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 30,711 | 30,711 | 39,259 | 88,230 |
Revenue | 727 | 727 | 648 | 533 |
EBITDA | (1,187) | (1,187) | (645) | (4,963) |
Net Income | (1,692) | (1,692) | (1,226) | (6,337) |
Total Assets | 9,664 | 9,664 | 12,313 | 14,233 |
Total Debt | 243 | 243 | 69 | 2,339 |
SynCore Biotechnology Company Comparisons
Industry
Financing
Details
SynCore Biotechnology Company Competitors (35)
One of SynCore Biotechnology Company’s 35 competitors is China Resources Pharmaceutical Group, a Corporation company based in Hong Kong, Hong Kong.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
China Resources Pharmaceutical Group | Corporation | Hong Kong, Hong Kong | ||||
Roche | Corporation | Basel, Switzerland | ||||
Novavax | Corporation | Gaithersburg, MD | ||||
EMD Serono | Corporation | Boston, MA | ||||
Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel |
SynCore Biotechnology Company Patents
SynCore Biotechnology Company Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2018205544-A1 | Treatment of pancreatic cancer | Active | 05-Jan-2017 | ||
US-20230035723-A1 | Treatment of pancreatic cancer | Pending | 05-Jan-2017 | ||
EP-3565530-A1 | Treatment of pancreatic cancer | Pending | 05-Jan-2017 | ||
US-20190380994-A1 | Treatment of pancreatic cancer | Inactive | 05-Jan-2017 | ||
EP-3565530-A4 | Treatment of pancreatic cancer | Pending | 05-Jan-2017 | A61K31/337 |
SynCore Biotechnology Company Signals
SynCore Biotechnology Company FAQs
-
When was SynCore Biotechnology Company founded?
SynCore Biotechnology Company was founded in 2008.
-
Where is SynCore Biotechnology Company headquartered?
SynCore Biotechnology Company is headquartered in Yilan City, Taiwan.
-
What is the size of SynCore Biotechnology Company?
SynCore Biotechnology Company has 33 total employees.
-
What industry is SynCore Biotechnology Company in?
SynCore Biotechnology Company’s primary industry is Biotechnology.
-
Is SynCore Biotechnology Company a private or public company?
SynCore Biotechnology Company is a Public company.
-
What is SynCore Biotechnology Company’s stock symbol?
The ticker symbol for SynCore Biotechnology Company is 4192.
-
What is the current stock price of SynCore Biotechnology Company?
As of 29-Apr-2025 the stock price of SynCore Biotechnology Company is $0.92.
-
What is the current market cap of SynCore Biotechnology Company?
The current market capitalization of SynCore Biotechnology Company is $32.4M.
-
What is SynCore Biotechnology Company’s current revenue?
The trailing twelve month revenue for SynCore Biotechnology Company is $727K.
-
Who are SynCore Biotechnology Company’s competitors?
China Resources Pharmaceutical Group, Roche, Novavax, EMD Serono, and Teva Pharmaceutical Industries are some of the 35 competitors of SynCore Biotechnology Company.
-
What is SynCore Biotechnology Company’s annual earnings per share (EPS)?
SynCore Biotechnology Company’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »